On December 19, Morgan Stanley analyst Jeffrey Hung downgraded PTC Therapeutics, Inc. (NASDAQ:PTCT) from Equalweight to Underweight, within the biotechnology industry.
This article presents an overview of the 5 Extreme Dividend Stocks With Upside Potential. For a detailed overview of such stocks, read our article, 12 Extreme Dividend Stocks With Upside Potential...